Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension
- PMID: 10458725
- DOI: 10.1161/01.cir.100.8.869
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension
Abstract
Background: Coadministration of phentermine and fenfluramine (phen/fen) effectively treats obesity and possibly addictive disorders. The association of fenfluramine and certain other anorexic agents with serious side effects, such as cardiac valvulopathy and primary pulmonary hypertension (PPH), limits the clinical utility of these drugs. Development of new medications that produce neurochemical effects like phen/fen without causing unwanted side effects would be a significant therapeutic breakthrough.
Methods and results: We tested the hypothesis that fenfluramine (and other anorexic agents) might increase the risk of PPH through interactions with serotonin (5-HT) transporters. Because 5-HT transporter proteins in the lung and brain are identical, we examined, in rat brain, the effects of selected drugs on 5-HT efflux in vivo and monoamine transporters in vitro as a generalized index of transporter function. Our data show that drugs known or suspected to increase the risk of PPH (eg, aminorex, fenfluramine, and chlorphentermine) are 5-HT transporter substrates, whereas drugs that have not been shown to increase the risk of PPH are less potent in this regard.
Conclusions: We speculate that medications that are 5-HT transporter substrates get translocated into pulmonary cells where, depending on the degree of drug retention, their intrinsic drug toxicity, and individual susceptibility, PPH could develop as a response to high levels of these drugs or metabolites. Emerging evidence suggests that it is possible to develop transporter substrates devoid of adverse side effects. Such medications could have therapeutic application in the management of obesity, drug dependence, depression, and other disorders.
Similar articles
-
Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.Synapse. 2000 May;36(2):102-13. doi: 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#. Synapse. 2000. PMID: 10767057
-
Therapeutic and adverse actions of serotonin transporter substrates.Pharmacol Ther. 2002 Jul;95(1):73-88. doi: 10.1016/s0163-7258(02)00234-6. Pharmacol Ther. 2002. PMID: 12163129 Review.
-
Serotonin releasing agents. Neurochemical, therapeutic and adverse effects.Pharmacol Biochem Behav. 2002 Apr;71(4):825-36. doi: 10.1016/s0091-3057(01)00669-4. Pharmacol Biochem Behav. 2002. PMID: 11888573 Review.
-
1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.Neuropsychopharmacology. 2001 May;24(5):492-501. doi: 10.1016/S0893-133X(00)00221-9. Neuropsychopharmacology. 2001. PMID: 11282249
-
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.Eur J Pharmacol. 2002 Jun 7;445(1-2):69-81. doi: 10.1016/s0014-2999(02)01751-x. Eur J Pharmacol. 2002. PMID: 12065196
Cited by
-
A Review of Serotonin in the Developing Lung and Neonatal Pulmonary Hypertension.Biomedicines. 2023 Nov 14;11(11):3049. doi: 10.3390/biomedicines11113049. Biomedicines. 2023. PMID: 38002049 Free PMC article. Review.
-
The changing face of pulmonary hypertension diagnosis: a historical perspective on the influence of diagnostics and biomarkers.Pulm Circ. 2020 Feb 4;10(1):2045894019892801. doi: 10.1177/2045894019892801. eCollection 2020 Jan-Mar. Pulm Circ. 2020. PMID: 32110383 Free PMC article. Review.
-
Serotonylated fibronectin is elevated in pulmonary hypertension.Am J Physiol Lung Cell Mol Physiol. 2012 Jun 15;302(12):L1273-9. doi: 10.1152/ajplung.00082.2012. Epub 2012 Apr 20. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22523280 Free PMC article.
-
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.Adv Pharmacol. 2014;69:71-106. doi: 10.1016/B978-0-12-420118-7.00002-0. Adv Pharmacol. 2014. PMID: 24484975 Free PMC article. Review.
-
Stimulants and the lung : review of literature.Clin Rev Allergy Immunol. 2014 Feb;46(1):82-100. doi: 10.1007/s12016-013-8376-9. Clin Rev Allergy Immunol. 2014. PMID: 23760760 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
